Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

10.51 +0.42 (+4.11%)
Streaming Delayed Price Updated: 1:02 PM EDT, Jun 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,223,144
Open 10.20
Bid (Size) 10.50 (3)
Ask (Size) 10.51 (8)
Prev. Close 10.09
Today's Range 10.12 - 10.69
52wk Range 6.780 - 24.76
Shares Outstanding 109,588,527
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions
Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s... 
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
What's Driving the Market Sentiment Around 10x Genomics?
Via Benzinga

Performance

YTD
-26.0%
-26.0%
1 Month
+10.3%
+10.3%
3 Month
-0.8%
-0.8%
6 Month
-35.0%
-35.0%
1 Year
-52.6%
-52.6%

More News

Read More
Forecasting The Future: 7 Analyst Projections For 10x Genomics
Via Benzinga
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration
Via Benzinga
Topics Government
Exposures Political
Powell, Mayville Engineering, Graham Corporation, Hyster-Yale Materials Handling, and 10x Genomics Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Earnings Scheduled For May 8, 2025
Via Benzinga
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why 10x Genomics Stock Was Sliding This Week
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
1 Small-Cap Stock with Exciting Potential and 2 to Turn Down
Via StockStory
3 Volatile Stocks Walking a Fine Line
Via StockStory
Analyst Expectations For 10x Genomics's Future
Via Benzinga
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks Under $10 Walking a Fine Line
Via StockStory
10x Genomics CEO Calls NIH The 'Foundational Jewel' Of Biomedical Progress, Says 40% To 50% Of Revenue Supported By Academic And Government Research Funding — Pulls Full Year Revenue Guidance
Via Benzinga
10x Genomics’s (NASDAQ:TXG) Q1: Strong Sales But Quarterly Revenue Guidance Significantly Misses Expectations
Via StockStory
10x Genomics (TXG) Reports Q1: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood Pours $9.8 Million In Robinhood Despite Crypto Revenue Slump, Keeps Dumping Palantir Ahead Of Earnings
Via Benzinga
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant
Via Benzinga
3 Cash-Heavy Stocks in the Doghouse
Via StockStory
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs
Via Benzinga
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know
Via StockStory
Topics Artificial Intelligence Government World Trade
Exposures Artificial Intelligence Political Tariff
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Reasons to Sell TXG and 1 Stock to Buy Instead
Via StockStory
1 Stock Under $50 on Our Watchlist and 2 to Ignore
Via StockStory
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties
Via Benzinga

Frequently Asked Questions

Is 10x Genomics, Inc. - Common Stock publicly traded?
Yes, 10x Genomics, Inc. - Common Stock is publicly traded.
What exchange does 10x Genomics, Inc. - Common Stock trade on?
10x Genomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 10x Genomics, Inc. - Common Stock?
The ticker symbol for 10x Genomics, Inc. - Common Stock is TXG on the Nasdaq Stock Market
What is the current price of 10x Genomics, Inc. - Common Stock?
The current price of 10x Genomics, Inc. - Common Stock is 10.51
When was 10x Genomics, Inc. - Common Stock last traded?
The last trade of 10x Genomics, Inc. - Common Stock was at 06/10/25 01:02 PM ET
What is the market capitalization of 10x Genomics, Inc. - Common Stock?
The market capitalization of 10x Genomics, Inc. - Common Stock is 1.15B
How many shares of 10x Genomics, Inc. - Common Stock are outstanding?
10x Genomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.